Molecular Diagnostics tests in Dubai & UAE

Compare available Molecular Diagnostics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

781

Listed price range

550.00–150,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Molecular Diagnostics test prices

Showing 601–615 of 781 matching tests.

Molecular Diagnostics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-6076 PDX1 Gene Maturity-Onset Diabetes of the Young Type 4 (MODY4) Genetic Test This genetic test identifies pathogenic variants in the PDX1 gene associated with Maturity-Onset Diabetes of the Young Type 4 (MODY4).	Peripheral whole blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PDX1 gene", "Coding exons and splice-site boundaries"] Parameters [] Preparation ["No specific fasting required", "No medication or diet changes needed"] Indications ["Diagnosis of MODY4", "Differentiation from Type 1 and Type 2 Diabetes", "Familial risk assessment", "Guiding targeted therapy"] Measurement technique Confirm with laboratory Codes LOINC: 88503-0 ICD-10: E13.9, E11.9 Clinical summary This genetic test identifies pathogenic variants in the PDX1 gene associated with Maturity-Onset Diabetes of the Young Type 4 (MODY4).
TEST-655 Periodontal Multiplex Detection & Differentiation (P. gingivalis, A. actinomycetemcomitans, F. nucleatum, T. forsythia) Test This test detects RNA from four key periodontal pathogens to aid in the diagnosis and targeted therapy of gum disease.	Gingival crevicular fluid (gum scrape) or saliva swab	Phone result: 36 hours; full email report: 4th working day	1,300.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["RNA of P. gingivalis", "RNA of A. actinomycetemcomitans", "RNA of F. nucleatum", "RNA of T. forsythia"] Parameters [] Preparation [] Indications ["Diagnosis of periodontal disease", "Guiding targeted antimicrobial therapy", "Monitoring treatment response"] Measurement technique Confirm with laboratory Codes LOINC: 100339-8 ICD-10: K05.30 Clinical summary This test detects RNA from four key periodontal pathogens to aid in the diagnosis and targeted therapy of gum disease.
TEST-2725 PGAP3 Gene Analysis Test This test evaluates the PGAP3 gene for pathogenic variants associated with Hyperphosphatasia with Intellectual Disability Syndrome Type 4 (HPMRS4). It uses Next-Generation Sequenci...	Peripheral blood or dried blood spot (FTA card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PGAP3 gene sequence", "Single nucleotide variants", "Small insertions/deletions", "Copy number changes"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed therapies"] Indications ["Suspected Hyperphosphatasia with Intellectual Disability Syndrome Type 4 (HPMRS4)", "Clinical diagnosis of Mabry syndrome", "Family planning for affected families"] Measurement technique Confirm with laboratory Codes LOINC: 101179-2 ICD-10: Q87.8 Clinical summary This test evaluates the PGAP3 gene for pathogenic variants associated with Hyperphosphatasia with Intellectual Disability Syndrome Type 4 (HPMRS4). It uses Next-Generation Sequencing to detect various types of genetic alterations.
TEST-5023 PHEX Gene Hypophosphatemic Rickets (X‑linked) Genetic Test This test analyzes the PHEX gene to identify genetic variants causing X-linked hypophosphatemic rickets (XLH).	Peripheral whole blood (EDTA) or FTA card; also accepts extracted genomic DNA	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PHEX gene sequence", "Single-nucleotide variants (SNVs)", "Insertions/deletions (indels)", "Copy-number variants (CNV)"] Parameters [{"name": "Gene Coverage", "reference_range": "22 exons + flanking intronic regions"}, {"name": "Diagnostic Yield", "reference_range": ">95% in clinically defined XLH"}] Preparation ["No fasting required", "No medication adjustments required unless instructed by your doctor"] Indications ["Suspected X-linked hypophosphatemic rickets (XLH)", "Family history of XLH", "Low serum phosphate with renal phosphate wasting", "Elevated FGF23 levels"] Measurement technique Confirm with laboratory Codes LOINC: 92823-5 ICD-10: E83.31 Clinical summary This test analyzes the PHEX gene to identify genetic variants causing X-linked hypophosphatemic rickets (XLH).
TEST-3304 PIEZO1 Gene (Dehydrated Hereditary Stomatocytosis) Genetic Test This genetic test analyzes the PIEZO1 gene for mutations causing Dehydrated Hereditary Stomatocytosis (DHS), a rare form of hemolytic anemia.	Whole Blood (EDTA), Extracted DNA, or FTA Card	21–28 Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PIEZO1 gene mutations", "Pathogenic variants (SNVs/indels)"] Parameters [] Preparation ["No specific fasting required", "Continue all prescribed medications unless advised otherwise by your physician"] Indications ["Diagnosis of Dehydrated Hereditary Stomatocytosis", "Family screening for DHS"] Measurement technique Confirm with laboratory Codes LOINC: 88511-0 ICD-10: D58.8 Clinical summary This genetic test analyzes the PIEZO1 gene for mutations causing Dehydrated Hereditary Stomatocytosis (DHS), a rare form of hemolytic anemia.
TEST-2083 PIK3CA Gene Cowden Syndrome Type 5 Genetic Test This test detects pathogenic variants in the PIK3CA gene associated with Cowden syndrome type 5, a hereditary cancer predisposition syndrome.	Whole Blood (EDTA), Extracted DNA, or One Drop Blood on FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PIK3CA gene", "Single nucleotide variants (SNVs)", "Insertions/deletions (indels)"] Parameters [{"name": "PIK3CA Gene Variants", "reference_range": "Negative for pathogenic/likely pathogenic variants"}] Preparation ["Mandatory pre-test genetic counselling session", "Inform counsellor of recent blood transfusions or pregnancy"] Indications ["Individuals with a personal or family history suggestive of Cowden syndrome", "Confirmation of clinical diagnosis", "Risk assessment for hereditary cancer predisposition"] Measurement technique Confirm with laboratory Codes LOINC: 94074-4 ICD-10: Q85.81, Z15.01, Z15.09 Clinical summary This test detects pathogenic variants in the PIK3CA gene associated with Cowden syndrome type 5, a hereditary cancer predisposition syndrome.
TEST-1217 PIK3CA Mutation Analysis (Exon 7, 9 & 20) Test This test identifies somatic mutations in exons 7, 9, and 20 of the PIK3CA gene within tumor tissue.	Archival tissue specimen (FFPE block, biopsy slides, or surgical pathology cuts)	7–8 working days	1,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Somatic mutations in PIK3CA gene exons 7, 9, and 20"] Parameters [] Preparation [] Indications ["Guiding precision oncology in breast cancer", "Guiding precision oncology in endometrial cancer", "Guiding precision oncology in other PIK3CA-related cancers"] Measurement technique Confirm with laboratory Codes LOINC: 81253-0 ICD-10: C50.9, C54.1 Clinical summary This test identifies somatic mutations in exons 7, 9, and 20 of the PIK3CA gene within tumor tissue.
TEST-16 PIK3CA Mutation Analysis Test This test identifies somatic mutations within the PIK3CA gene in solid tumor tissue.	Formalin-fixed paraffin-embedded (FFPE) tissue block	6 Calendar Days	1,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Somatic PIK3CA gene mutations", "Tumor cellularity"] Parameters [] Preparation [] Indications ["Guiding targeted therapy in breast cancer", "Guiding targeted therapy in colon cancer", "Guiding targeted therapy in lung cancer"] Measurement technique Confirm with laboratory Codes LOINC: 94552-5 ICD-10: Z13.89 Clinical summary This test identifies somatic mutations within the PIK3CA gene in solid tumor tissue.
TEST-5413 PLA2G6 Gene (PARK14) Parkinson Genetic Test This test evaluates the entire coding region and splice sites of the PLA2G6 gene for pathogenic variants associated with early-onset Parkinson's disease and NBIA type 2B.	Peripheral Whole Blood (EDTA tube) or Dried Blood Spot (FTA card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single-nucleotide variants (SNVs)", "Small insertions and deletions (indels)", "Copy-number variations (CNVs)", "Pathogenic variants in PLA2G6 gene coding region and splice sites"] Parameters [] Preparation ["No specific fasting required", "Inform the lab of any medications being taken"] Indications ["Clinical suspicion of early-onset Parkinson's disease (PARK14)", "Clinical suspicion of Neurodegeneration with Brain Iron Accumulation (NBIA) type 2B", "Family history suggestive of PLA2G6-related disorders", "Genetic counselling for individuals with relevant symptoms or family history"] Measurement technique Confirm with laboratory Codes LOINC: 83259-8 ICD-10: G20, E75.5 Clinical summary This test evaluates the entire coding region and splice sites of the PLA2G6 gene for pathogenic variants associated with early-onset Parkinson's disease and NBIA type 2B.
TEST-2910 Plasminogen Activator Inhibitor-1 (PAI-1 / SERPINE-1) 4G/5G Genotyping Test This test evaluates the genetic polymorphism (4G/5G) in the SERPINE-1 gene, which influences PAI-1 levels and thrombotic risk.	Whole blood (EDTA)	9 days	2,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SERPINE-1 gene polymorphism (4G/5G)", "PAI-1 levels (indirectly via genotype)"] Parameters [] Preparation ["Complete Genomics Clinical Information Requisition Form (Form 20)", "Remain hydrated", "Inform phlebotomist of anticoagulant medications"] Indications ["Assessment of inherited thrombophilia risk", "Guidance for personalized prevention strategies", "Evaluation in patients with unexplained thrombosis"] Measurement technique Confirm with laboratory Codes LOINC: 49927-1 ICD-10: Z15.09, D68.59 Clinical summary This test evaluates the genetic polymorphism (4G/5G) in the SERPINE-1 gene, which influences PAI-1 levels and thrombotic risk.
TEST-757 Plasmodium vivax RNA Detection Qualitative Test This test detects the presence of Plasmodium vivax RNA in blood samples using real-time PCR.	Whole blood or dried blood spots	24–36 hours (telephonic report)	800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Plasmodium vivax RNA"] Parameters [] Preparation ["No fasting required", "Continue all prescribed medications", "Inform phlebotomist about anticoagulant therapy"] Indications ["Suspected vivax malaria", "Travel history to endemic zones", "Early diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 77915-1 ICD-10: B51.9 Clinical summary This test detects the presence of Plasmodium vivax RNA in blood samples using real-time PCR.
TEST-2922 PML-RARA t(15;17)(q22;q12) Gene Rearrangement Quantitative MRD Monitoring Test This test quantitatively measures the level of the PML-RARA fusion transcript in blood or bone marrow to monitor minimal residual disease (MRD) in patients with Acute Promyelocytic...	5 mL whole blood (Lavender Top EDTA) OR Bone Marrow Aspirate (EDTA)	24–48 hours (Sample Mon/Wed/Fri by 9 AM; Report Tue/Thu/Sat)	700.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PML-RARA fusion transcript levels", "Minimal Residual Disease (MRD)"] Parameters [{"name": "PML-RARA Fusion Transcript Level", "reference_range": "Undetectable (Sensitivity 10^-4 to 10^-5)"}] Preparation ["No fasting required for peripheral blood collection", "Specific instructions provided by clinical team for bone marrow aspiration", "Ensure MRD Requisition Form (Form 22) is complete with historical data"] Indications ["Monitoring treatment response in APL", "Detecting early molecular relapse in APL", "Guiding therapeutic decisions in APL"] Measurement technique Confirm with laboratory Codes LOINC: 42911-8 ICD-10: C92.41, C92.40, Z85.6 Clinical summary This test quantitatively measures the level of the PML-RARA fusion transcript in blood or bone marrow to monitor minimal residual disease (MRD) in patients with Acute Promyelocytic Leukemia (APL).
TEST-2918 PML::RARA t(15;17)(q22;q12) Gene Rearrangement Quantitative PCR Test This diagnostic test evaluates the presence and quantity of the PML::RARA fusion transcript, a genetic marker specific for acute promyelocytic leukaemia (APL).	Whole blood	2 business days (sample Mon/Wed/Fri by 9 AM → report Tue/Thu/Sat)	1,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PML::RARA fusion transcript", "t(15;17)(q22;q12) translocation"] Parameters [{"name": "PML::RARA Fusion Transcript Quantification", "reference_range": "Negative or low levels (specific threshold depends on laboratory standards)"}] Preparation ["No fasting required", "Provide a blood sample", "Provide a completed Genomics Clinical Information Requisition Form (Form 20)", "Include a list of current medications, especially anticoagulants"] Indications ["Diagnosis of acute promyelocytic leukaemia (APL)", "Remission assessment in APL", "Minimal residual disease (MRD) monitoring in APL", "Resistance detection during APL therapy"] Measurement technique Confirm with laboratory Codes LOINC: 33696-8 ICD-10: C92.4 Clinical summary This diagnostic test evaluates the presence and quantity of the PML::RARA fusion transcript, a genetic marker specific for acute promyelocytic leukaemia (APL).
TEST-1224 PML/RARA Qualitative Gene Fusion (bcr1 & bcr3) Test This test detects the presence or absence of the PML/RARA gene fusion transcript, a specific genetic marker for acute promyelocytic leukemia (APL).	Bone marrow aspirate or peripheral blood (EDTA)	2–3 days	700.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PML/RARA fusion transcript (bcr1 isoform)", "PML/RARA fusion transcript (bcr3 isoform)"] Parameters [] Preparation ["No specific fasting required", "Inform physician about anticoagulant therapy"] Indications ["Diagnosis of suspected APL", "Confirmation of APL diagnosis", "Monitoring for minimal residual disease in APL"] Measurement technique Confirm with laboratory Codes LOINC: 92895-0 ICD-10: C92.40 Clinical summary This test detects the presence or absence of the PML/RARA gene fusion transcript, a specific genetic marker for acute promyelocytic leukemia (APL).
TEST-1209 PML/RARA Quantitative [Single Form] Test This test quantitatively measures the PML/RARA fusion transcript, a genetic marker specific to Acute Promyelocytic Leukemia (APL). It is used for diagnosis, MRD monitoring, and tre...	Peripheral Whole Blood (EDTA); Bone Marrow Aspirate if clinically indicated	2–3 Business Days	850.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PML/RARA fusion transcript (t(15;17))", "Minimal Residual Disease (MRD)"] Parameters [{"name": "PML/RARA Fusion Transcript", "reference_range": "Undetectable (or quantitative value reported)"}] Preparation ["No special dietary or medication preparation is required for a peripheral blood draw.", "Patients scheduled for bone marrow aspiration must follow fasting instructions and medication adjustment guidelines provided by their hematologist."] Indications ["Diagnosis of suspected Acute Promyelocytic Leukemia (APL)", "Monitoring treatment response in APL patients", "Detection of Minimal Residual Disease (MRD) in APL", "Prediction of relapse in APL"] Measurement technique Confirm with laboratory Codes LOINC: 76490-6 ICD-10: C92.4 Clinical summary This test quantitatively measures the PML/RARA fusion transcript, a genetic marker specific to Acute Promyelocytic Leukemia (APL). It is used for diagnosis, MRD monitoring, and treatment response assessment.

Category overview

Molecular Diagnostics: overview

When complex health questions arise, evaluating your health at the cellular level provides the definitive clarity necessary for proactive care. At DNA Labs UAE, our Molecular Diagnostics services harness the power of advanced nucleic acid amplification and real-time PCR technologies to detect diseases with unparalleled sensitivity. From identifying viral loads to pinpointing genetic markers, our specialized molecular testing in the UAE gives your healthcare provider the precise data needed to customize your medical strategy. Trust in one of the leading diagnostic labs in Dubai and the UAE to process your samples with rigorous confidentiality and exceptionally fast, accurate turnaround times. Step forward with absolute confidence. View our molecular diagnostics profiles below, request a seamless home sample collection, or contact our specialized team to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Molecular Diagnostics tests in Dubai & UAE

Molecular Diagnostics test prices

Molecular Diagnostics: overview

Use the test details as a conversation starter

Related Molecular Diagnostics categories